ライフサイエンスコーパス: bone densitometry

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 quire risk factor information in addition to bone densitometry.

2 ors were significantly related to performing bone densitometry.

3 likely to receive cholesterol screening and bone densitometry.

4 magnetic resonance (MR) imaging (2.6%), and bone densitometry (1.5%) (percentages do not add up to 1

5 Bone densitometry and histomorphometry in lymphoma-beari

6 rved bone mass at 6 and 12 mo as measured by bone densitometry and histomorphometry.

7 It may help achieve appropriate use of bone densitometry and may allow convenient dissemination

8 Bone densitometry and micro-computed tomography (microCT

9 menopausal women were less likely to undergo bone densitometry and to receive a prescription medicati

10 who had recently (within 2 weeks) undergone bone densitometry and were found to have osteoporosis.

11 al glucocorticoids did not routinely undergo bone densitometry and/or receive prescription medication

12 ee percent of the study population underwent bone densitometry, and 42% were prescribed a medication

13 amination, spine magnetic resonance imaging, bone densitometry, and brain magnetic resonance angiogra

14 erol screening, colorectal cancer screening, bone densitometry, and mammography during survivorship y

15 on analysis, with potential in arthrography, bone densitometry, and metastases surveillance.

16 microarchitecture and adds value to standard bone densitometry, and the Fracture Risk Assessment Tool

17 hysicians increased use and understanding of bone densitometry, changed management of osteoporosis, a

18 Clinical and bone densitometry (dual x-ray absorptiometry [DXA]) reco

19 te among older men the cost-effectiveness of bone densitometry followed by 5 years of oral bisphospho

20 Bone densitometry followed by bisphosphonate therapy for

21 ive Services Task Force guidelines recommend bone densitometry for all women older than 65 years, ide

22 A major barrier to wider use of bone densitometry has been a lack of reports that are co

23 Factors associated with not undergoing bone densitometry in adjusted logistic models included m

24 , and radiation-free approach may complement bone densitometry in assessing risk of osteoporotic frac

25 n the face of increasing use of all types of bone densitometry in the diagnosis and management of ost

26 d-type (WT) littermate mice was evaluated by bone densitometry, microcomputed tomography, and analysi

27 All women underwent bone densitometry of the lumbar spine and hip.

28 screening tool either for early referral to bone densitometry or for occult spinal fractures.

29 elationship between calcium nephrolithiasis, bone densitometry scoring, and bone mineral density (BMD

30 nclude benefits and limitations of pediatric bone densitometry techniques, proper interpretation of t

31 d testing, cervical and colon screening, and bone densitometry) than matched controls.

32 The use of bone densitometry to diagnose and predict fracture risk

33 Clinical reporting of bone densitometry to primary care physicians increased u

34 ffice laboratory monitoring, radiographs, or bone densitometry to supplement their income (i.e., down

35 ent (intervention 33% versus control 38%) or bone densitometry use (intervention 8% versus control 8%

36 use (intervention 32% versus control 34%) or bone densitometry use (intervention 9% versus control 5%

37 Our data suggest that bone densitometry used for assessment of the condition o

38 e femoral neck were measured at baseline and bone densitometry was repeated after 3.5 years by dual-e

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。